tradingkey.logo
搜尋

Spyre Therapeutics Inc

SYRE
添加自選
98.330USD
-3.170-3.12%
收盤 07-31 16:00美東報價延遲15分鐘
8.54B總市值
虧損本益比TTM

SYRE 財務數據

透過專為投資者打造的一站式數據看板,全面查看 Spyre Therapeutics Inc 的財務狀況。平台將複雜的財務報表整理為可自定義的視圖,助您更輕鬆地進行財務分析。您可以查看最新年度財務報告,也可以通過利潤表、資產負債表和現金流量表,按季度分析公司表現。借助實時財務指標,持續追蹤公司的經營狀況和市場表現更加便捷。

Spyre Therapeutics Inc財報日曆

最新發布
5月 5, 2026
每股收益 / 預測值
-0.88/-0.67
營業收入 / 預測值
--/0.00
報告期
FY2025 財報
營業收入(YoY)
--
--
每股收益(YoY)
-2.42
45.22%
分析師評級
BUY
2026/07/31
單季報
單季報+年報
單季報
年報
YOY
隱藏空白列
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
財務指標
每股收益
-18.25%-0.88
18.30%-0.83
86.35%-0.19
28.99%-0.61
38.15%-0.74
74.71%-1.02
85.48%-1.36
98.49%-0.86
75.42%-1.20
18.43%-4.02
---9.34
---56.79
---4.89
---4.93
---20.17
----
----
----
----
----
營業收入
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
10.08%688.00K
-85.46%198.00K
-95.39%168.00K
-87.56%174.00K
-95.44%625.00K
--1.36M
--3.64M
--1.40M
--13.70M
淨利潤
-54.12%-69.00M
-11.07%-62.53M
83.80%-11.18M
5.46%-36.72M
-2.09%-44.77M
10.90%-56.30M
-72.11%-69.03M
82.11%-38.84M
-138.07%-43.86M
-235.67%-63.18M
-119.96%-40.11M
-872.45%-217.08M
24.61%-18.42M
7.94%-18.82M
10.21%-18.23M
-226.84%-22.32M
-34.13%-24.44M
9.99%-20.45M
-12.61%-20.31M
68.11%-6.83M
利潤率
----
----
----
----
----
----
----
----
----
----
----
---31552.47%
---9304.04%
---11203.57%
---3007.54%
----
----
----
----
----
毛利率
----
----
----
----
----
----
----
----
----
----
----
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
資產負債率
----
----
----
----
----
----
----
----
----
-100.00%0.00%
--0.00%
--0.00%
--0.00%
--0.02%
--0.00%
----
----
----
----
----
營業收入
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
10.08%688.00K
-85.46%198.00K
-95.39%168.00K
-87.56%174.00K
-95.44%625.00K
--1.36M
--3.64M
--1.40M
--13.70M
營業利潤
-41.21%-75.64M
6.66%-57.17M
-2.70%-56.89M
-17.64%-51.94M
-12.13%-53.57M
-28.27%-61.25M
-66.62%-55.39M
-147.91%-44.15M
-154.04%-47.77M
-149.21%-47.75M
-77.25%-33.24M
20.58%-17.81M
23.06%-18.81M
6.26%-19.16M
7.58%-18.75M
-234.42%-22.42M
-34.22%-24.44M
10.25%-20.44M
-11.97%-20.29M
68.90%-6.71M
淨利潤
-54.12%-69.00M
-11.07%-62.53M
83.80%-11.18M
5.46%-36.72M
-2.09%-44.77M
10.90%-56.30M
-72.11%-69.03M
82.11%-38.84M
-138.07%-43.86M
-235.67%-63.18M
-119.96%-40.11M
-872.45%-217.08M
24.61%-18.42M
7.94%-18.82M
10.21%-18.23M
-226.84%-22.32M
-34.13%-24.44M
9.99%-20.45M
-12.61%-20.31M
68.11%-6.83M
流動資產
34.08%763.95M
27.82%777.78M
19.84%504.60M
23.66%538.83M
16.93%569.77M
78.16%608.47M
104.46%421.08M
81.64%435.74M
998.08%487.27M
448.57%341.53M
150.49%205.95M
148.21%239.89M
-38.87%44.38M
-37.04%62.26M
-30.03%82.22M
-28.07%96.65M
-52.05%72.60M
-33.98%98.89M
-18.62%117.51M
-16.99%134.37M
流動負債總額
20.49%85.16M
8.56%58.69M
-19.58%46.27M
275.46%83.06M
65.07%70.68M
69.05%54.06M
28.23%57.54M
-90.47%22.12M
238.83%42.82M
118.19%31.98M
153.83%44.87M
1364.09%232.23M
-22.46%12.64M
-27.24%14.66M
-13.46%17.68M
-23.01%15.86M
-49.65%16.30M
22.51%20.14M
42.37%20.43M
29.67%20.60M
總資產
34.08%763.95M
27.82%777.78M
19.83%504.60M
23.57%538.83M
16.85%569.78M
77.99%608.48M
103.16%421.09M
79.06%436.07M
829.60%487.60M
380.52%341.86M
126.36%207.26M
128.22%243.53M
-36.93%52.45M
-35.28%71.14M
-29.05%91.57M
-27.40%106.71M
-49.17%83.17M
-31.98%109.93M
-17.07%129.06M
-15.00%146.98M
總負債
6.85%93.14M
-31.03%62.55M
-47.17%49.50M
34.66%83.06M
6.40%87.17M
23.73%90.68M
42.92%93.70M
-75.68%61.68M
335.76%81.93M
251.69%73.29M
173.05%65.56M
1024.50%253.57M
-12.61%18.80M
-19.80%20.84M
-11.00%24.01M
-19.34%22.55M
-46.03%21.51M
19.27%25.98M
39.38%26.98M
35.37%27.96M
總權益
39.00%670.81M
38.13%715.24M
39.01%455.10M
21.74%455.77M
18.96%482.61M
92.80%517.80M
131.04%327.39M
3826.71%374.38M
1105.50%405.67M
433.89%268.57M
109.76%141.70M
-111.94%-10.05M
-45.42%33.65M
-40.07%50.30M
-33.82%67.56M
-29.29%84.16M
-50.18%61.66M
-39.97%83.94M
-25.09%102.08M
-21.83%119.02M
經營淨額
-39.95%-57.37M
-19.84%-44.58M
-26.16%-37.12M
25.20%-46.56M
-43.63%-40.99M
-19.86%-37.20M
14.96%-29.42M
-274.02%-62.25M
-61.86%-28.54M
-71.09%-31.04M
-129.61%-34.60M
19.49%-16.64M
32.86%-17.63M
5.85%-18.14M
11.36%-15.07M
-1092.94%-20.67M
-34.48%-26.26M
-12.47%-19.27M
3.06%-17.00M
110.72%2.08M
投資淨額
92855.74%56.58M
-45.07%-247.41M
-41.51%25.00M
165.55%79.00M
99.94%-61.00K
-383.51%-170.54M
143.78%42.74M
-1882.81%-120.52M
-691.34%-104.96M
-351.94%-35.27M
-691.74%-97.63M
801.33%6.76M
-31.09%17.75M
44.88%14.00M
185.60%16.50M
101.58%750.00K
176.98%25.76M
-66.24%9.66M
-0.12%5.78M
16.56%-47.36M
融資淨額
9704.00%12.26M
38.66%312.81M
-136.33%-4.64M
103.06%731.00K
-99.93%125.00K
37.89%225.60M
201.99%12.78M
-99.83%360.00K
1721550.00%172.16M
2045175.00%163.61M
-9539.23%-12.53M
390.59%209.99M
-16.67%10.00K
-110.00%-8.00K
-111.37%-130.00K
22393.75%42.80M
-96.69%12.00K
-99.68%80.00K
343.02%1.14M
-100.15%-192.00K

常見問題

Spyre Therapeutics Inc的流動資產是多少?

根據Spyre Therapeutics Inc的FY2025財報,流動資產為777.78M(同比變化27.82)。

Spyre Therapeutics Inc的總資產是多少?

根據Spyre Therapeutics Inc的FY2025財報,Spyre Therapeutics Inc的總資產為777.78M(同比變化27.82)。

Spyre Therapeutics Inc的總負債是多少?

根據Spyre Therapeutics Inc的FY2025財報,Spyre Therapeutics Inc的總責任為62.55M(同比變化-31.03)。

Spyre Therapeutics Inc的總權益是多少?

根據Spyre Therapeutics Inc的FY2025財報,Spyre Therapeutics Inc的總權益為715.24M(同比變化38.13)。

Spyre Therapeutics Inc的淨營業收入是多少?

根據Spyre Therapeutics Inc的FY2025財報,Spyre Therapeutics Inc的淨營業收入為-219.56M(同比變化-5.27)。

Spyre Therapeutics Inc的淨投資是多少?

根據Spyre Therapeutics Inc的FY2025財報,Spyre Therapeutics Inc的淨投資為-143.47M(同比變化59.39)。

Spyre Therapeutics Inc的淨融資是多少?

根據Spyre Therapeutics Inc的FY2025財報,Spyre Therapeutics Inc的淨融資為309.02M(同比變化-24.79)。

Spyre Therapeutics Inc的每股收益(EPS)是多少?

根據Spyre Therapeutics Inc的FY2025財報,每股收益(EPS)為-2.42(同比變化45.22)。

Spyre Therapeutics Inc的淨利潤是多少?

根據Spyre Therapeutics Inc的FY2025財報,淨利潤為-155.20M(同比變化25.39)。

Spyre Therapeutics Inc的股東權益回報率(ROE)是多少?

根據Spyre Therapeutics Inc的FY2025財報,股東權益回報率(ROE)為-33.69(同比變化70.76)。

Spyre Therapeutics Inc的資產回報率(ROA)是多少?

根據Spyre Therapeutics Inc的FY2025財報,資產回報率(ROA)為-22.39(同比變化48.85)。

Spyre Therapeutics Inc的營業利潤是多少?

根據Spyre Therapeutics Inc的FY2025財報,營業利潤為-219.56M(同比變化-5.27)。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有